Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 12-2022 | 12-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,312 | -11,114 | -996 | -248 | N/A |
| Income taxes - deferred | N/A | N/A | 30 | N/A | N/A |
| Accounts payable and accrued liabilities | -9,333 | 8,388 | N/A | N/A | N/A |
| Other Working Capital | -9,951 | 9,369 | 577 | -67 | -3 |
| Other Operating Activity | 10,528 | -7,978 | -654 | -2 | 0 |
| Operating Cash Flow | $-16,068 | $-1,336 | $-1,044 | $-316 | $-3 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | N/A | -45,186 | N/A |
| Sale Of Investment | N/A | N/A | 36,170 | N/A | N/A |
| Other Investing Activity | 4,961 | -273 | 0 | 0 | -3,190 |
| Investing Cash Flow | $4,961 | $-273 | $36,170 | $-45,186 | $-3,190 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 300 | N/A | 499 | 300 | N/A |
| Debt Issued | N/A | N/A | 50 | N/A | N/A |
| Debt Repayment | -5,073 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 0 | 47,472 | N/A |
| Common Stock Repurchased | -354 | N/A | -36,113 | -25 | N/A |
| Other Financing Activity | 17,921 | 0 | 0 | -1,766 | 205 |
| Financing Cash Flow | $12,794 | $N/A | $-35,564 | $45,981 | $205 |
| Beginning Cash Position | 2,479 | 4,088 | 479 | N/A | 0 |
| End Cash Position | 4,165 | 2,479 | 41 | 479 | N/A |
| Net Cash Flow | $1,686 | $-1,609 | $-438 | $479 | $-2,988 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,068 | -1,336 | -1,044 | -316 | -3 |
| Free Cash Flow | -16,068 | -1,336 | -1,044 | -316 | -3 |